WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care (NYSE: FMS), the world’s leading company devoted to renal therapy, said today that the U.S. Agency for Healthcare Research and Quality officially recognized the company’s Patient Safety Organization (PSO.) The certification by the U.S. Secretary of the Department of Health and Human Services, the first for a dialysis organization, furthers Fresenius Medical Care’s mission of continuously improving patient safety and health care quality. The purpose of a PSO is to establish a framework by which doctors and other health care providers may voluntarily report information to PSOs, on a privileged and confidential basis, to collect and analyze patient safety events. Regulations outline how the PSO may utilize data and act as a resource for health care providers to understand and minimize the risks and hazards in delivering patient care.
